The Joint Corp. (JYNT)
NASDAQ: JYNT · Real-Time Price · USD
11.34
-0.36 (-3.08%)
At close: Jul 30, 2025, 4:00 PM
11.50
+0.16 (1.41%)
After-hours: Jul 30, 2025, 4:00 PM EDT
The Joint Revenue
The Joint had revenue of $13.08M in the quarter ending March 31, 2025, with 7.33% growth. This brings the company's revenue in the last twelve months to $52.79M, up 71.05% year-over-year. In the year 2024, The Joint had annual revenue of $51.90M with 10.47% growth.
Revenue (ttm)
$52.79M
Revenue Growth
+71.05%
P/S Ratio
3.33
Revenue / Employee
$71,725
Employees
736
Market Cap
173.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 51.90M | 4.92M | 10.47% |
Dec 31, 2023 | 46.98M | -54.27M | -53.60% |
Dec 31, 2022 | 101.25M | 21.24M | 26.55% |
Dec 31, 2021 | 80.01M | 21.33M | 36.34% |
Dec 31, 2020 | 58.68M | 10.23M | 21.12% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 57.37B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
JYNT News
- 6 days ago - The Joint Corp. to Host Conference Call on Thursday, August 7th to Discuss Second Quarter 2025 Results - GlobeNewsWire
- 23 days ago - The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region - GlobeNewsWire
- 4 weeks ago - The Joint Chiropractic Launches Official Mobile App on iOS and Android - PRNewsWire
- 5 weeks ago - The Joint Corp. Signs Binding Agreement to Sell 31 Corporate Clinics in Arizona and New Mexico and to Acquire Regional Developer Rights in the Northwest Region and Refranchises Five Corporate Clinics in the Kansas City Region, Tracking to Become Largest Pure Play Chiropractic Care Franchise System - GlobeNewsWire
- 7 weeks ago - The Joint Corp. Names Business Transformation and Growth Expert Scott J. Bowman Chief Financial Officer - GlobeNewsWire
- 7 weeks ago - The Joint Corp. Announces $5 Million Stock Repurchase Program - GlobeNewsWire
- 2 months ago - The Joint Corp. Appoints Sandi Karrmann as Director - GlobeNewsWire
- 2 months ago - The Joint Corp. Announces Christopher M. Grandpre Elected as Director - GlobeNewsWire